New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Glenmark released Picture Post Cards on World Vitiligo Day
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated